By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...

Gout is one of the oldest documented human illnesses. It develops when sharp crystals form inside joints, triggering intense swelling and pain, and is ...

Access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio expands our genetic engineering toolkit and strengthens our ability to speed up and optimize strain development across Dyadic’s ...

Yi Li, professor of horticultural plant breeding biotechnology in the College of Agriculture, Health and Natural Resources ...

Earlier this year, researchers at Children's Hospital of Philadelphia and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a ...

Penn and CHOP researchers want to develop urea cycle disorder treatments using CRISPR gene-editing therapy. Get unlimited access to Inquirer.com and The Inquirer App, plus 5 articles each month to ...

A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based ...

Ben Lamm, founder of Colossal Biosciences, aims to revive extinct species like the woolly mammoth using advanced genetic ...

The protection the iconic plane trees—devastated across Greece, and Europe by a disease—has won the University of Ioannina ...

Insects that feed on starch can find veritable feasts in corn, pea, and bean crops or warehouses. It is no coincidence that the ancestors of these commercial plants developed α-amylase inhibitor ...

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered ...

The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...